Literature DB >> 2105115

Single dose cefotaxime plus metronidazole versus three dose cefuroxime plus metronidazole as prophylaxis against wound infection in colorectal surgery: multicentre prospective randomised study.

D C Rowe-Jones1, A L Peel, R D Kingston, J F Shaw, C Teasdale, D S Cole.   

Abstract

OBJECTIVE: To establish whether a single preoperative dose of cefotaxime plus metronidazole was as effective as a standard three dose regimen of cefuroxime plus metronidazole in preventing wound infection after colorectal surgery.
DESIGN: Prospective randomised allocation to one of two prophylactic antibiotic regimens in a parallel group trial. Group sequential analyses of each 250 patients were performed.
SETTING: 14 District general and teaching hospitals. PATIENTS: 1018 Adults having colorectal operations were randomised, of whom 943 were evaluated. Demographic features, conditions requiring surgery, and operative procedures were similar in the two groups. Most patients had surgery for carcinoma of the colon or rectum.
INTERVENTIONS: Group 1 received cefotaxime 1 g intravenously plus metronidazole 500 mg intravenously preoperatively. Group 2 received cefuroxime 1.5 g intravenously plus metronidazole 500 mg intravenously preoperatively, followed by cefuroxime 750 mg intravenously plus metronidazole 500 mg intravenously eight hours and 16 hours postoperatively. MAIN OUTCOME MEASURES: Development of surgical wound infection (as evidenced by the presence of pus), death, or discharge from hospital.
RESULTS: Wound condition was scored on a five point scale on alternate days until discharge or for up to 20 days postoperatively. Wound infection rates were: group 1, 32/453 (7.1%; 95% confidence interval 4.7% to 9.4%); group 2, 33/454 (7.3%; 95% confidence interval 4.9% to 9.6%). Death rates (group 1: 26/470 (5.5%); group 2: 31/471 (6.6%], the incidence of postoperative complications, the median duration of hospital stay (12 days), and antibiotic tolerance were all similar in the two groups. Pooled data from groups 1 and 2 showed that wound infections were more frequent when minor faecal contamination had occurred at operation and when the duration of operation exceeded 90 minutes (greater than 90 min 11.2% of cases; less than 90 min 4.8%) and were associated with an extended hospital stay.
CONCLUSIONS: A single preoperative dose of cefotaxime plus metronidazole is an efficacious as a three dose regimen of cefuroxime plus metronidazole in preventing wound infection after colorectal surgery and has practical advantages in eliminating the need for postoperative antibiotics.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2105115      PMCID: PMC1661869          DOI: 10.1136/bmj.300.6716.18

Source DB:  PubMed          Journal:  BMJ        ISSN: 0959-8138


  21 in total

1.  Comparison of two prophylactic single-dose intravenous antibiotic regimes in the treatment of patients undergoing elective colorectal surgery in a district general hospital.

Authors:  R D Kingston; R S Kiff; J S Duthie; S Walsh; A Spicer; J Jeacock
Journal:  J R Coll Surg Edinb       Date:  1989-08

2.  Desacetylcefotaxime--another broad spectrum cephalosporin?

Authors:  P C Fuchs; R N Jones; A L Barry; S D Allen; L W Ayers; M Pfaller
Journal:  J Antimicrob Chemother       Date:  1989-01       Impact factor: 5.790

3.  Ceftriaxone and metronidazole as single-dose prophylaxis in colorectal surgery.

Authors:  D W Burdon; M R Keighley
Journal:  S Afr Med J       Date:  1987-06-20

4.  Single dose mezlocillin versus three dose cefuroxime plus metronidazole for prophylaxis in large bowel surgery.

Authors:  D C Rowe-Jones; D S Cole
Journal:  J Hosp Infect       Date:  1988-08       Impact factor: 3.926

5.  Serious postoperative bleeding associated with a single intravenous dose of cefuroxime and metronidazole.

Authors:  R D Kingston; J Duthie
Journal:  J Hosp Infect       Date:  1986-01       Impact factor: 3.926

6.  Comparison between systemic and oral antimicrobial prophylaxis in colorectal surgery.

Authors:  M R Keighley; Y Arabi; J Alexander-Williams; D Youngs; D W Burdon
Journal:  Lancet       Date:  1979-04-28       Impact factor: 79.321

7.  Single-dose cefmetazole versus multiple dose cefoxitin for prophylaxis in abdominal surgery.

Authors:  J T DiPiro; L S Welage; B A Levine; P E Wing; J A Stanfield; H V Gaskill; D S Scarfoni; J J Schentag; T A Bowden; J S Williams
Journal:  J Antimicrob Chemother       Date:  1989-04       Impact factor: 5.790

Review 8.  Antimicrobial prophylaxis of gastrointestinal surgical procedures and treatment of intraabdominal infections.

Authors:  L Danziger; E Hassan
Journal:  Drug Intell Clin Pharm       Date:  1987-05

9.  Short-term prophylaxis with cefuroxime in colorectal surgery for cancer.

Authors:  S Colizza; S De Fazio; A Addari; R Grande; G Cucchiara
Journal:  J Surg Oncol       Date:  1987-08       Impact factor: 3.454

10.  Single dose mezlocillin versus three dose cefuroxime plus metronidazole for the prophylaxis of wound infection after large bowel surgery.

Authors:  R S Stubbs; N J Griggs; J P Kelleher; I K Dickinson; N Moat; D M Rimmer
Journal:  J Hosp Infect       Date:  1987-05       Impact factor: 3.926

View more
  14 in total

1.  Antiseptic wick: does it reduce the incidence of wound infection following appendectomy?

Authors:  Gerald T McGreal; Aislinn Joy; Brian Manning; John L Kelly; Joseph A O'Donnell; W William O Kirwan; H Paul Redmond
Journal:  World J Surg       Date:  2002-03-18       Impact factor: 3.352

2.  Itemized bill: novel method to audit the process of laparoscopic cholecystectomy.

Authors:  Khawaja Mohammad Inam Pal; Mushtaq Ahmed
Journal:  World J Surg       Date:  2003-05-02       Impact factor: 3.352

3.  Single dose prophylaxis in colonic surgery.

Authors: 
Journal:  BMJ       Date:  1990-02-17

4.  Audit of major colorectal and biliary surgery to reduce rates of wound infection.

Authors:  B D Hancock
Journal:  BMJ       Date:  1990-10-20

5.  Single-dose cefodizime as infection prophylaxis in abdominal surgery: a prospective multicenter study.

Authors:  F Thalhammer; F Traunmüller; H J Böhming; D Depisch; W Ilias; U Hollenstein; G Salem; W Wayand; H Burgmann; S Breyer
Journal:  Infection       Date:  1998 Mar-Apr       Impact factor: 3.553

6.  Prescribing practice and cost of antibacterial prophylaxis for surgery at a US Veteran Affairs hospital.

Authors:  R A Ryono; K S Jones; R W Coleman; M Holodniy
Journal:  Pharmacoeconomics       Date:  1996-12       Impact factor: 4.981

Review 7.  Cefotaxime. An update of its pharmacology and therapeutic use.

Authors:  P A Todd; R N Brogden
Journal:  Drugs       Date:  1990-10       Impact factor: 9.546

Review 8.  Metronidazole. A therapeutic review and update.

Authors:  C D Freeman; N E Klutman; K C Lamp
Journal:  Drugs       Date:  1997-11       Impact factor: 9.546

9.  Comparison of cefotaxime plus metronidazole versus cefoxitin for prevention of wound infection after abdominal surgery.

Authors:  L Kow; J Toouli; J Brookman; P J McDonald
Journal:  World J Surg       Date:  1995 Sep-Oct       Impact factor: 3.352

10.  A randomized trial of one versus three doses of Augmentin as wound prophylaxis in at-risk abdominal surgery.

Authors:  T Bates; J V Roberts; K Smith; K A German
Journal:  Postgrad Med J       Date:  1992-10       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.